{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:24:32Z","timestamp":1761294272647,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41433-020-01344-6","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T12:08:19Z","timestamp":1614686899000},"page":"160-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and tolerability of polyvinylpyrrolidone-iodine 0.6% treatment in adenoviral keratoconjunctivitis: a Prospective Randomized Controlled Study"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2741-6247","authenticated-orcid":false,"given":"Gabriella","family":"Ricciardelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-0289","authenticated-orcid":false,"given":"Giuseppe","family":"Giannaccare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-5973","authenticated-orcid":false,"given":"Antonio","family":"Di Zazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Coassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6826-7957","authenticated-orcid":false,"given":"Vincenzo","family":"Scorcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario R.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Allegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Cennamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0494-6293","authenticated-orcid":false,"given":"Federico","family":"Bernabei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Mencucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"1344_CR1","first-page":"224","volume":"2","author":"AJ Mueller","year":"1993","unstructured":"Mueller AJ, Klauss V. Main sources of infection in 145 cases of epidemic keratoconjunctivitis. Ger J Ophthalmol. 1993;2:224\u20137.","journal-title":"Ger J Ophthalmol"},{"unstructured":"Aoki A, Isobe K, Ohno S. Nationwide surveillance program of epidemic conjunctivitis in Japan. In: Bialasiewicz AA, Schaal KP, editors. Infectious diseases of the eye. Philadelphia: Butterworth-Heinemann; 1994. p. 309\u201316.","key":"1344_CR2"},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1001\/archopht.119.10.1487","volume":"119","author":"Jost Hillenkamp","year":"2001","unstructured":"Hillenkamp Jost, Reinhard T, Ross RS, B\u00f6hringer D, Cartsburg O, Roggendorf M, et al. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2 cidofovir and 1% cyclosporine. A pilot study. Arch Ophthalmol. 2001;119:1497\u20131491.","journal-title":"Arch Ophthalmol."},{"doi-asserted-by":"publisher","unstructured":"Varu DM, Rhee MK, Akpek EK, Amescua G, Farid M, Garcia-Ferrer FJ, et al. American Academy of Ophthalmology Preferred Practice Pattern Cornea and External Disease Panel. Conjunctivitis Preferred Practice Pattern. Ophthalmology. 2019;126:P94\u2013P169. https:\/\/doi.org\/10.1016\/j.ophtha.2018.10.020.","key":"1344_CR4","DOI":"10.1016\/j.ophtha.2018.10.020"},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2018.05.012","volume":"194","author":"JS Pepose","year":"2018","unstructured":"Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R. Randomized, controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194:7\u201315.","journal-title":"Am J Ophthalmol."},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.15585\/mmwr.mm6748a4","volume":"67","author":"K OYong","year":"2018","unstructured":"OYong K, Killerby M, Pan CY, Huynh T, Green NM, Wadford DA, et al. Outbreak of epidemic keratoconjunctivitis caused by human adenovirus type D53 in an eye care clinic - Los Angeles County, 2017. Morb Mortal Wkly Rep. 2018;67:1347\u20139.","journal-title":"Morb Mortal Wkly Rep."},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1167\/iovs.05-0438","volume":"46","author":"SA Harvey","year":"2005","unstructured":"Harvey SA, Romanowski EG, Yates KA, Gordon YJ. Adenovirus directed ocular innate immunity: the role of conjunctival defensin-like chemokines (IP-10, I-TAC) and phagocytic human defensin-\u03b1. Investig Ophthalmol Vis Sci. 2005;46:3657\u201365.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/IDR.S162669","volume":"11","author":"DI Chigbu","year":"2018","unstructured":"Chigbu DI, Labib BA. Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist 2018;11:981\u201393.","journal-title":"Infect Drug Resist"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/2013.jamaophthalmol.513","volume":"131","author":"R Sambursky","year":"2013","unstructured":"Sambursky R, Trattler W, Tauber S, Starr C, Friedberg M, Boland T, et al. Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. JAMA Ophthalmol 2013;131:17\u201322.","journal-title":"JAMA Ophthalmol"},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/bjophthalmol-2014-306508","volume":"99","author":"KY Kam","year":"2015","unstructured":"Kam KY, Ong HS, Bunce C, Ogunbowale L, Verma S. Sensitivity and specificity of the AdenoPlus point-of-care system in detecting adenovirus in conjunctivitis patients at an ophthalmic emergency department: a diagnostic accuracy study. Br J Ophthalmol. 2015;99:1186\u20139.","journal-title":"Br J Ophthalmol."},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.mayocpiqo.2017.06.001","volume":"1","author":"KK Holtz","year":"2017","unstructured":"Holtz KK, Townsend KR, Furst JW, Myers JF, Binnicker MJ, Quigg SM, et al. An assessment of the adenoplus point-of-care test for diagnosing adenoviral conjunctivitis and its effect on antibiotic stewardship. Mayo Clin Proc Innov Qual Outcomes 2017;1:170\u20135.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"1344_CR12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/104303402320138952","volume":"10","author":"M Olive","year":"2002","unstructured":"Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4 T-cell epitope. Hum Gene Ther 2002;10:1167\u201378.","journal-title":"Hum Gene Ther"},{"doi-asserted-by":"crossref","unstructured":"Workshop, Dry eye. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5:108\u201352.","key":"1344_CR13","DOI":"10.1016\/S1542-0124(12)70083-6"},{"key":"1344_CR14","first-page":"15","volume":"7","author":"A Bialasiewicz","year":"2007","unstructured":"Bialasiewicz A. Adenoviral Keratoconjuunctivitis. Sultan Qaboos Univ Med J. 2007;7:15\u201323.","journal-title":"Sultan Qaboos Univ Med J."},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.4321\/S0365-66912006000900001","volume":"81","author":"J Rajaiya","year":"2006","unstructured":"Rajaiya J, Chodosh J. New paradigms in infectious eye disease: adenoviral keratoconjunctivitis. Arch Soc Esp Oftalmol. 2006;81:493\u20138.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"1344_CR16","first-page":"273","volume":"269","author":"HG Burgert","year":"2002","unstructured":"Burgert HG, Ruzsics Z, Obermeier S, Hilgendorf A, Windheim M, Elsing A. Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol. 2002;269:273\u2013318.","journal-title":"Curr Top Microbiol Immunol."},{"key":"1344_CR17","first-page":"341","volume":"28","author":"H Freyler","year":"1976","unstructured":"Freyler H, Sehorst W. The fate of corneal infiltrations in cases of epidemic keratoconjunctvitis. Wien Klin Wochenschr. 1976;28:341\u20133.","journal-title":"Wien Klin Wochenschr"},{"key":"1344_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2217\/cpr.13.50","volume":"10","author":"J-M Lachapelle","year":"2013","unstructured":"Lachapelle J-M, Castel O, Casado AF, Leroy B, Micali G, Tennstedt D, et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin Pract. 2013;10:579\u201392.","journal-title":"Clin Pract"},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1111\/aos.13416","volume":"95","author":"N Kovalyuk","year":"2017","unstructured":"Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, et al. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol. 2017;95:e686\u2013e692.","journal-title":"Acta Ophthalmol."},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/jop.2018.0122","volume":"35","author":"KA Yates","year":"2019","unstructured":"Yates KA, Shanks RMQ, Kowalski RP, Romanowski EG. The in vitro evaluation of povidone-iodine against multiple ocular adenoviral types. J Ocul Pharmacol Ther. 2019;35:132\u20136.","journal-title":"J Ocul Pharmacol Ther."},{"key":"1344_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3109\/02713683.2014.964419","volume":"40","author":"RD Pinto","year":"2015","unstructured":"Pinto RD, Lira RP, Abe RY, Zacchia RS, Felix JP, Pereira AV, et al. Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res. 2015;40:870\u20137.","journal-title":"Curr Eye Res."},{"unstructured":"BASF SE\u2014Care Chemical Division. PVP-iodine grades. Technical information, August 2010, https:\/\/industries.basf.com\/bin\/bws\/documentDownload.en.8805242644949.","key":"1344_CR22"},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1120672118802541","volume":"29","author":"R Musumeci","year":"2019","unstructured":"Musumeci R, Bandello F, Martinelli M, Calaresu E, Cocuzza CE. In vitro bactericidal activity of 0.6% povidone-iodine eye drops formulation. Eur J Ophthalmol. 2019;29:673\u20137.","journal-title":"Eur J Ophthalmol."},{"key":"1344_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/ICU.0b013e3283477cb5","volume":"22","author":"HE Kaufman","year":"2011","unstructured":"Kaufman HE. Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol. 2011;22:290\u20133.","journal-title":"Curr Opin Ophthalmol"},{"key":"1344_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3109\/02713683.2012.692846","volume":"37","author":"HE Kaufman","year":"2012","unstructured":"Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012;37:654\u201360.","journal-title":"Curr Eye Res"},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0161-6420(02)00992-2","volume":"109","author":"J Hillenkamp","year":"2002","unstructured":"Hillenkamp J, Reinhard T, Ross RS, B\u00f6hringer D, Cartsburg O, Roggendorf M, et al. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology. 2002;109:845\u201350.","journal-title":"Ophthalmology"},{"key":"1344_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.antiviral.2006.04.007","volume":"71","author":"L Lenaerts","year":"2006","unstructured":"Lenaerts L, Naesens L. Antiviral therapy for adenovirus infections. Antivir Res. 2006;71:172\u201380.","journal-title":"Antivir Res."},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-2006-926633","volume":"223","author":"N Monnerat","year":"2006","unstructured":"Monnerat N, Bossart W, Thiel MA. Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study. Klin Monbl Augenheilkd. 2006;223:349\u201352.","journal-title":"Klin Monbl Augenheilkd."},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.5866\/3.3.617","volume":"3","author":"KP Sunil","year":"2011","unstructured":"Sunil KP, Raja BP, Jagadish RG, Uttam A. Povidone iodine-revisited. Indian J Dent Adv. 2011;3:617\u201320.","journal-title":"Indian J Dent Adv."},{"key":"1344_CR30","first-page":"1071","volume":"55","author":"KL Visscher","year":"2009","unstructured":"Visscher KL, Hutnik CM, Thomas M. Evidence-based treatment of acute infective conjunctivitis: breaking the cycle of antibiotic prescribing. Can Fam Physician. 2009;55:1071\u20135.","journal-title":"Can Fam Physician"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01344-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01344-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01344-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:04:52Z","timestamp":1641294292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01344-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-01344-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}